[1]SIEGEL RL,MILLER KD,FUCHS HE,et al.Cancer statistics,2021[J].CA:A Cancer Journal for Clinicians,2021,71(1):7-33.
[2] Global Burden of Disease 2019 Cancer Collaboration,KOCARNIK JM,COMPTON K,et al.Cancer incidence,mortality,years of life lost,years lived with disability,and disability-adjusted life years for 29 cancer groups from 2010 to 2019:A systematic analysis for the global burden of disease study 2019[J].JAMA Oncol,2022,8(3):420-444.
[3] WOOD LD,CANTO MI,JAFFEE EM,et al.Pancreatic cancer:Pathogenesis,screening,diagnosis,and treatment[J].Gastroenterology,2022,163(2):386-402.e1.
[4] WU J,CAI J.Dilemma and challenge of immunotherapy for pancreatic cancer[J].Dig Dis Sci,2021,66(2):359-368.
[5] PARK W,CHAWLA A,O' REILLY EM.Pancreatic cancer:A review[J].JAMA,2021,326(9):851-862.
[6] SINGHI AD,KOAY EJ,CHARI ST,et al.Early detection of pancreatic cancer:Opportunities and challenges[J].Gastroenterology,2019,156(7):2024-2040.
[7] HU Y,ZHU S,XU R,et al.Delta-Catenin attenuates medulloblastoma cell invasion by targeting EMT pathway[J].Front Genet,2022,13:867872.
[8] CHEN Z,LEE H J,KIM H,et al.δ-Catenin promotes cell migration and invasion via Bcl-2-regulated suppression of autophagy in prostate cancer cells[J].Am J Cancer Res,2022,12(1):108-122.
[9] VU V,LIGHT T,SULLIVAN B,et al.P120 Catenin potentiates constitutive E-cadherin dimerization at the plasma membrane and regulates trans binding[J].Curr Biol,2021,31(14):3017-3027.e7.
[10] LIU WW,HU J,WANG R,et al.Cytoplasmic p120ctn promotes gefitinib resistance in lung cancer cells by activating PAK1 and ERK pathway[J].Appl Immunohistochem Mol Morphol,2021,29(10):750-758.
[11] LIU D,ZHANG H,CUI M,et al.Hsa-miR-425-5p promotes tumor growth and metastasis by activating the CTNND1-mediated β-Catenin pathway and EMT in colorectal cancer[J].Cell Cycle,2020,19(15):1917-1927.
[12] TANG B,TANG F,WANG Z,et al.Overexpression of CTNND1 in hepatocellular carcinoma promotes carcinous characters through activation of Wnt/β-Catenin signaling[J].J Exp Clin Cancer Res,2016,35(1):82.
[13] MAYERLE J,FRIESS H,BUCHLER MW,et al.Up-regulation,nuclear import,and tumor growth stimulation of the adhesion protein p120 in pancreatic cancer[J].Gastroenterology,2003,124(4):949-960.
[14] LI TH,ZHAO BB,QIN C,et al.IFIT1 modulates the proliferation,migration and invasion of pancreatic cancer cells via Wnt/β-Catenin signaling[J].Cell Oncol,2021,44(6):1425-1437.
[15] LIU F,XIA Z,ZHANG M,et al.SMARCAD1 promotes pancreatic cancer cell growth and metastasis through Wnt/β-Catenin-mediated EMT[J].Int J Biol Sci,2019,15(3):636-646.
[16] LIU M,ZHANG Y,YANG J,et al.Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer[J].Gastroenterology,2021,160(5):1771-1783.
[17] ZHU L,TIAN Q,GAO H,et al.PROX1 promotes breast cancer invasion and metastasis through WNT/β-Catenin pathway via interacting with hnRNPK[J].Int J Biol Sci,2022,18(5):2032-2046.
[18] CAI K,CHEN S,ZHU C,et al.FOXD1 facilitates pancreatic cancer cell proliferation,invasion,and metastasis by regulating GLUT1-mediated aerobic glycolysis[J].Cell Death Dis,2022,13(9):765.
[19] MAO X,XU J,WANG W,et al.Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment:New findings and future perspectives[J].Mol Cancer,2021,20(1):131.
[20] LI J,KANG R,TANG D.Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma[J].Cancer Commun(Lond),2021,41(8):642-660.
[21] SCHACKMANN RCJ,TENHAGEN M,VAN DE VEN RAH,et al.P120-Catenin in cancer-mechanisms,models and opportunities for intervention[J].J Cell Sci,2013,126(Pt 16):3515-3525.
[22] SOTO E,YANAGISAWA M,MARLOW LA,et al.P120 Catenin induces opposing effects on tumor cell growth depending on E-cadherin expression[J].J Cell Biol,2008,183(4):737-749.
[23] THORESON MA,REYNOLDS AB.Altered expression of the Catenin p120 in human cancer:Implications for tumor progression[J].Differentiation,2002,70(9-10):583-589.
[24] TIAN W,YUAN H,QIN S,et al.Kaiso phosphorylation at threonine 606 leads to its accumulation in the cytoplasm,reducing its transcriptional repression of the tumour suppressor CDH1[J].Mol Oncol,2022,16(17):3192-3209.
[25] LOBANOVA Y,FILONOVA G,KAPLUN D,et al.TRIM28 regulates transcriptional activity of methyl-DNA binding protein Kaiso by SUMOylation[J].Biochimie,2023,206:73-80.
[26] DAI SD,WANG Y,ZHANG JY,et al.Upregulation of δ-Catenin is associated with poor prognosis and enhances transcriptional activity through Kaiso in non-small-cell lung cancer[J].Cancer Sci,2011,102(1):95-103.
[27] LESSEY LR,ROBINSON SC,CHAUDHARY R,et al.Adherens junction proteins on the move-from the membrane to the nucleus in intestinal diseases[J].Front Cell Dev Biol,2022,10:998373.
[28] PIERRE CC,HERCULES SM,YATES C,et al.Dancing from bottoms up - roles of the POZ-ZF transcription factor Kaiso in cancer[J].Biochim Biophys Acta Rev Cancer,2019,1871(1):64-74.
[29] JING J,LIU J,WANG Y,et al.The role of ZBTB38 in promoting migration and invasive growth of bladder cancer cells[J].Oncol Rep,2019,41(3):1980-1990.
[30] CAI K,DENG L,ZHENG D,et al.MICAL1 facilitates pancreatic cancer proliferation,migration,and invasion by activating WNT/β-Catenin pathway[J].J Transl Med,2022,20(1):528.
[31] CHEN L,XU Z,LI Q,et al.USP28 facilitates pancreatic cancer progression through activation of Wnt/β-Catenin pathway via stabilising FOXM1[J].Cell Death Dis,2021,12(10):887.